Lobbied Canada

Command Palette

Search for a command to run...

Elizabeth Reid

Consul and Senior Trade Commissioner for Canada in Atlanta, Global Affairs Canada (GAC)1 communications in the past year

Lobbied by

Air Transport Association of Canada (ATAC)

1

Discussion about marketing Canadian Maintenance, Repair and Overhaul companies on international stage. Discussions about digital ID for travel in the global travel continuum. Discussion on government investment in infrastructure for remote and northern airports. Working with Transport Canada Aviation Security on Enhanced Security measures harmonizing with the Transportation Security Administration and Department of Homeland Security requirements. Working with the Public Health Agency of Canada (PHAC) ensuring the Orders in Council make operational sense in their requirements in keeping the travelling public safe during the COVID-19 pandemic. Also ensuring that the Transport Canada Aviation Security and Civil Aviation are harmonized in the issuance of Interim Orders which regulate the Aviation Industry during the pandemic. Status of European Union (EU) Bilateral - The Canadian Government and the European Union entered into Bilaterals. The issues are its impact on costs and trade to our industry. Request funding from CanExport Associations Program (CEA) International Marketing assistance from Global Affairs Canada with regard to Aircraft Maintenance, Repair and Overhaul (MRO) and Flight Training. Passenger Bill of Rights, Foreign Ownership, Joint Ventures and the possible cost impacts to our industry and unintended consequences. (Formerly known as Bill C-49 Transportation Modernization Act) Participation in the development of mitigation measures for the use of Ethylene Glycol and Halon and Greenhouse Gases with Environment and Climate Change Canada, and Transport Canada Participation in stakeholder consultation with Health Canada on regulatory matters with regard to public safety and costs to the industry. Obtain support from relevant government departments in dealing with the European Union Emissions Trading Scheme to ensure fairness to Canadian companies. International Student Program in respect of streamlining the process to obtain student study permits for commercial pilot training in Canada and provide exemptions on the caps for foreign aviation students. (Imagine Education au/in Canada Brand program) with Global Affairs Canada and Immigration, Refugees and Citizenship Canada. Government consultation (Transport Canada) with stakeholders on the privatization of CATSA and its impact on the industry and the cost to passengers. Acts to amend the Aeronautics Act and the Access to Information Act and to make consequential amendments to other Acts with regard to all sections, particularly the provisions enabling safety management systems and the protection of safety data from public dissemination. Federal jurisdiction at aerodromes as it pertains to noise responsibilities. We do not want the province/municipality to enforce noise around airports. We oppose attempts by provinces/municipalities from attempting to usurp the federal powers. The Federal Government regulation in this case refers to the Aeronautics Act. Excise Tax Act with regard to Reduction of Air Travellers Security Charge. Excise Tax Act with regards to the reduction of Aviation Fuel Taxes. Enhancement and growth of the Canadian Council for Aviation and Aerospace to cover all aviation human resource issues. Encouraging the implementation of Safety Management Systems throughout Canadian commercial aviation. Discussions with Transport Canada and Employment & Social Development Canada on removing barriers to entry for people who want to become pilots or aircraft maintenance engineers or technicians. Discussions with regard to the on-going management of the Air Carrier Security Measures (Document is classified). Discussions with Public Safety Canada regarding, and support for, actions to prevent Human Trafficking. Discussions on the Statutory Review of the Canada Transportation Act with respect to administerial advice on policies Discussions about restrictions (timelines, airspace and procedures onboard aircraft) in the context of special events with regards to public sa

Innovative Medicines Canada

1

Canada's Drug Agency policies as it relates to reimbursement recommendation decision-making process and framework Biomanufacturing and Life Sciences Strategy (BLSS) as it relates to the biopharmaceutical industry. Federal policies that relate to possible models of pharmacare Federal Buy Canadian Procurement Policy as it relates to government drug procurement practices and the implications for the biopharmaceutical industry Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time-to-reimbursement and streamline federal/provincial listing processes Policy measures to ensure security of drug supply in Canada and preserve Canada's attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations National Strategy for Drugs for Rare Diseases World Trade Organization (WTO) issues concerning the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPs) with respect to the protection of data, Access to Medicines, and TRIPs "flexibility" World Intellectual Property Organization (WIPO) issues concerning the biopharmaceutical industry World Health Organization (WHO) issues concerning the biopharmaceutical industry Scientific Research and Educational Design (SR&ED) Tax Credit in respect of updating the system and increasing the expenditure limit for refundable credits Pharmaceutical pricing policy issues arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB) Patented Medicines Regulations as it relates to the regulation and protection of biopharmaceutical products Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive Patented Medicines (Notice of Compliance) Regulations as it relates to the regulation of intellectual property for biopharmaceutical products Patent Act as it relates to reporting requirements and pricing guidelines, and the protection of intellectual property in biopharmaceutical products Income Tax Act as it relates to biopharmaceutical products Health Canada's Regulatory Roadmap for Health Products and Food as it relates to the biopharmaceutical industry Free trade agreements as they relate to the biopharmaceutical industry Food and Drugs Act and Regulations and the Import and Export Permits Act with respect to cross-border trade as it relates to the export of Canadian biopharmaceuticals Food and Drug Regulations as it relates to data protection and the regulation and protection of biopharmaceutical products Canadian Institutes of Health Research (CIHR) Clinical Research Initiative as it relates to public/private research and development partnerships Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry